Ji Yaofeng, Liu Yin, Yang Na
Department of Otolaryngology, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China.
Exp Ther Med. 2016 Oct;12(4):2383-2386. doi: 10.3892/etm.2016.3684. Epub 2016 Sep 7.
Rhinitis is a common global disorder that impacts on the quality of life of the sufferer and caregivers. Treatment for pediatric rhinitis is empirical and does not include a detailed history of the allergy triggers or allergy testing. Thus, allergen avoidance advice is not tailored to the child's sensitivities, which may result in adenoid hypertrophy. However, infant onset rhinitis, especially its relationship with respiratory viruses, remains to be further clarified. Rhinitis basically involves inflammation of the upper nasal lining, presenting typically with symptoms of runny nose (rhinorrhea), nasal blockage, and/or sneezing. While not typically fatal, it does impose significant health, psychological, and monetary burden to its sufferers, and is thus considered a global health problem. Previous findings showed that immunotherapy had significant clinical efficacy in children with allergic rhinitis. The present review article aims to highlight recent perspectives pertaining to the rhinitis risk factors especially in pediatric patients.
鼻炎是一种常见的全球性疾病，会影响患者及其照料者的生活质量。小儿鼻炎的治疗是经验性的，不包括详细的过敏触发因素病史或过敏测试。因此，避免接触过敏原的建议并非根据孩子的敏感性量身定制，这可能会导致腺样体肥大。然而，婴儿期鼻炎，尤其是其与呼吸道病毒的关系，仍有待进一步阐明。鼻炎主要涉及鼻内上衬层的炎症，通常表现为流鼻涕、鼻塞和/或打喷嚏等症状。虽然通常不会致命，但它确实给患者带来了重大的健康、心理和经济负担，因此被视为一个全球性的健康问题。先前的研究结果表明，免疫疗法对过敏性鼻炎儿童具有显著的临床疗效。本综述文章旨在突出有关鼻炎风险因素的最新观点，尤其是在儿科患者中。
